Grauer & Weil India cash flow

Latest FY26

Cash from operations: ₹154cr+6.1% on FY25
Capital spending: ₹49.2cr+14.2% on FY25
Free cash flow: ₹105cr+2.6% on FY25
Cash from financing: −₹27.9cr−₹41.2 cr in FY25

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Adjustments to reconcile profit — non-cash items
	24.1	22.3	20.7	19.6
	2.8	2.6	3.8	1.8
	−36.9	−33.5	−26.0	−14.2
	−0.0	−0.0	−0.0	−0.1
Changes in working capital
	−17.8	−18.5	−10.2	17.4
	20.3	−17.3	−6.3	−53.2
	14.0	10.2	14.5	8.6
Cash from operating activities
	219	209	194	151
	192	199	203	152
	154	145	158	113
Cash from investing activities
	49.2	43.1	31.5	14.2
	2.0	5.3	0.3	0.9
	533	154	—	—
	169	—	—	—
	32.5	33.2	18.5	10.1
	−184	−123	−108	−116
Cash from financing activities
	2.8	2.6	3.8	1.8
	22.7	22.6	18.2	14.8
	−27.9	−41.2	−20.2	−18.4
	−58.3	−19.3	29.4	−21.3
Reference items
	197	188	188	154
	16.7%	16.7%	17.8%	15.8%
	105	102	126	98.8
	103	85.0	126	—
	₹2.31	₹2.25	₹2.79	₹2.18
	0.92×	0.92×	1.10×	1.01×
	2.8	2.6	3.8	1.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GRAUWEIL₹82.12

Grauer & Weil India Limited

· Chemicals

₹ CrorePeersAMAL ARCL CHEMCRUX DAICHI ELANTAS INDOKEM JYOTIRES KANCHIMcap ₹3,722 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	19.6	20.7	22.3	24.1
+ Finance Costs	1.8	3.8	2.6	2.8
+ Interest Income	-14.2	-26.0	-33.5	-36.9
+ Dividend Income	-0.1	-0.0	-0.0	-0.0
Changes in Working Capital
+ Inventories	17.4	-10.2	-18.5	-17.8
+ Trade Receivables — Current	-53.2	-6.3	-17.3	20.3
+ Trade Payables — Current	8.6	14.5	10.2	14.0
Cash from Operating Activities
Profit Before Tax (per I/S)	150.9	194.0	209.5	219.1
Cash from Operations (pre-tax)	152.3	203.1	198.9	192.0
Cash from Operating Activities	112.9	157.9	144.9	153.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	14.2	31.5	43.1	49.2
+ Disp of Fixed Assets	0.9	0.3	5.3	2.0
+ Purchase of Investments (Equity / Debt)	—	—	153.5	533.5
+ Sale of Investments (Equity / Debt)	—	—	—	169.4
+ Dividends Received — Investing	10.1	18.5	33.2	32.5
Cash from Investing Activities	-115.9	-108.3	-123.1	-184.2
Cash from Financing Activities
+ Interest Paid	1.8	3.8	2.6	2.8
+ Dividends Paid	14.8	18.2	22.6	22.7
Cash from Financing Activities	-18.4	-20.2	-41.2	-27.9
Net Changes in Cash	-21.3	29.4	-19.3	-58.3
Reference Items
EBITDA	154.0	187.8	188.3	196.6
EBITDA Margin %	15.78	17.81	16.70	16.68
Free Cash Flow (CFO − Capex)	98.8	126.4	101.9	104.6
Free Cash Flow to Equity	—	125.8	85.0	102.7
Free Cash Flow per Basic Share	2.18	2.79	2.25	2.31
Cash Flow to Net Income	1.01	1.10	0.92	0.92
Cash Paid for Interest	1.8	3.8	2.6	2.8

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.